The AGM Presentation from yesterday tells all... Page 4
Page #4 of the AGM Presentation says it all... It's a breakdown of what the company has done and where there were 1 yr ago from July 1 2012 b4 fda approval..
I don't care what ppl say about management, the bottom line is that type of execution blows away what any other company has done over 1 year as a 1 drug Biotech..
So let the nay sayers and bashers say all they want, but the fact is if anyone thinks that Page #4 justifies a stock at $5.60 then your more blind then Ray Charles, Stevie Wonder and Andrea Bocelli put together..
This will turn out to be one of the biggest opportunities ever to the upside as things develop into Anchor as the next 3-4 months play out..
We are talking about Fish oil(safe) here, any CEO would have got this product FDA approved. So, quit glorifying these numbnuts for getting high purity fish oil approved. Its all about PPS and return to investors. What good is a product if the investors can't reap the rewards?
REALLY genius.. If thats the case how come out of 70 mill people in the US that suffer from High Trygs, has ONLY the smallest market of 4 million people had a FDA approved drug to treat them..
Get REAL... Another one that doesn't have a clue...
Vascepa will be the 1st ever approved drug to treat this population and the 1st EVER drug to successfully be combined with Statins...
If it was so easy where have all the other drugs been for the last 10000 years!!
It's time to find a buyer for this company to give a new direction and increase the sale of Vascepa and Anchor. If it does not find a buyer, Amrin will just flounder away and get wasted. Time to find
a new management team or a partner.